首页> 外文OA文献 >Effect of Diagnosis (Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts in Transformation, or Acute Myeloid Leukemia AML) on Outcome of AML-Type Chemotherapy

【2h】

Effect of Diagnosis (Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts in Transformation, or Acute Myeloid Leukemia AML) on Outcome of AML-Type Chemotherapy

机译：诊断的影响（难治性贫血，过量爆炸，难治性贫血，转化中具有过度的爆炸，或急性髓性白血病AML）AML型化疗的结果

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Elihu Estey; Peter Thall; Miloslav Beran; Hagop Kantarjian; Sherry Pierce; Michael Keating;
展开▼
作者单位

展开▼
年度 1997
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Subanalysis of Patients with Secondary Acute Myeloid Leukemia (sAML) with Refractory Anemia with Excess of Blasts in Transformation (RAEB-T) Enrolled in a Phase 3 Study of CPX-351 Versus Conventional 7?+?3 Cytarabine and Daunorubicin [J] . Tara L. Lin, Geoffrey L. Uy, Matthew J. Wieduwilt, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：二次急性髓性白血病患者的细胞分析，其具有过量的转化血液（RAEB-T）的难治性贫血（RAEB-T）纳入CPX-351与常规7的第3阶段研究（RaEB-T）与常规7？+？3个月曲和Daunorubicin
2. Subanalysis of Patients with Secondary Acute Myeloid Leukemia (sAML) with Refractory Anemia with Excess of Blasts in Transformation (RAEB-T) Enrolled in a Phase 3 Study of CPX-351 Versus Conventional 7?+?3 Cytarabine and Daunorubicin [J] . Tara L. Lin, Geoffrey L. Uy, Matthew J. Wieduwilt, Biology of blood and marrow transplantation: journal of the American Society for Blood and Marrow Transplantation . 2018,第3期

机译：二次急性髓性白血病患者的细胞分析，其具有过量的转化血液（RAEB-T）的难治性贫血（RAEB-T）纳入CPX-351与常规7的第3阶段研究（RaEB-T）与常规7？+？3个月曲和Daunorubicin
3. Durable second complete remissions with oral melphalan in hypocellular Acute Myeloid Leukemia and Refractory Anemia with Excess Blast with normal karyotype relapsing after intensive chemotherapy [J] . Annika M. Whittle, Sylvia Feyler, David T. Bowen Leukemia Research Reports . 2013,第1期

机译：强化化疗后，经细胞马法兰治疗次细胞急性髓性白血病和难治性贫血并伴有过量冲击波的持久性第二次完全缓解，核型正常
4. Global Analysis of the Phosphoproteome of Human Blasts as a First Step to Discover Phosphorylation Biomarkers for the Treatment of Acute Myeloid Leukemia [C] . Heike Pfeifer, Felix Oppermann, Andreas Tebbe, American Society for Mass Spectrometry Conference on Mass Spectrometry and Allied Topics . 2011

机译：对人类爆炸磷蛋白酶的全局分析作为发现磷酸化生物标志物治疗急性髓性白血病的第一步
5. Homeobox gene HOXA7 and chemotherapy resistance in acute myeloid leukemia (AML). [D] . Asimolowo, Olaniyi Adewuyi. 2006

机译：同源盒基因HOXA7与急性髓细胞白血病（AML）的化疗耐药性。
6. Durable second complete remissions with oral melphalan in hypocellular Acute Myeloid Leukemia and Refractory Anemia with Excess Blast with normal karyotype relapsing after intensive chemotherapy [O] . Annika M. Whittle, Sylvia Feyler, David T. Bowen 2013

机译：强化化疗后口服马法兰治疗次细胞急性髓细胞白血病和难治性贫血伴过度爆炸的持久性第二次完全缓解核型正常
7. Subanalysis of Patients with Secondary Acute Myeloid Leukemia (sAML) with Refractory Anemia with Excess of Blasts in Transformation (RAEB-T) Enrolled in a Phase 3 Study of CPX-351 Versus Conventional 7 + 3 Cytarabine and Daunorubicin [O] . Tara L. Lin, Geoffrey L. Uy, Matthew J. Wieduwilt, 2018

机译：二次急性髓性白血病（SAML）患者的细胞分析，其难治性贫血具有过量的转化中的爆炸（RAEB-T）纳入CPX-351与常规7 + 3个月曲和DaUnorubicin的第3阶段研究

Effect of Diagnosis (Refractory Anemia With Excess Blasts, Refractory Anemia With Excess Blasts in Transformation, or Acute Myeloid Leukemia AML) on Outcome of AML-Type Chemotherapy

著录项

引文网络

相似文献

相关主题

期刊订阅